Get the Stockscreener App
2.10
4.11%
-0.09
Gelteq Ltd stock is traded at $2.10, with a volume of 40,460.
It is down -4.11% in the last 24 hours and down -18.92% over the past month.
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
See More
Previous Close:
$2.19
Open:
$2.25
24h Volume:
40,460
Relative Volume:
0.12
Market Cap:
$19.82M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+7.14%
1M Performance:
-18.92%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.8901
$2.3165
1-Week Range:
$1.8901
$2.3165
52-Week Range:
$1.42
$5.50
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
2.10 | 19.82M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Gelteq Ltd Stock (GELS) Latest News
Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan
“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelteq CEO to Present at Benchmark's Discovery Investor Conference - StockTitan
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl
Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal
Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn
Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World
Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World
Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan
Ins & OutsWeek Ending 11/15/2024 - substack.com
Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com
Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India
Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times
GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan
Argent Biopharma Lists New Shares on ASX - MSN
Biotech company Gelteq prices IPO at $4 per share - MSN
Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN
Maas Group Reports Record Results and Growth Strategy - MSN
Qualitas Limited Releases 2024 Governance Statement - MSN
Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha
WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN
Novatti Group Announces Hybrid Annual General Meeting - MSN
Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times
RooLife Group Announces AGM with Key Resolutions - MSN
Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN
Strike Resources Limited Announces Upcoming AGM Details - MSN
IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha
Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project
Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World
SkyView Investment Advisors LLC Boosts Stock Holdings in General Electric (NYSE:GE) - Defense World
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga
Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData
AST SpaceMobile registers shares in Antares reorg - MSN
AN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary - Benzinga
Cognition Therapeutics (NASDAQ:CGTX) Stock Quotes, Forecast and News Summary - Benzinga
Cingulate (NASDAQ:CING) Stock Quotes, Forecast and News Summary - Benzinga
Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Quotes, Forecast and News Summary - Benzinga
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
Hoth Therapeutics (NASDAQ:HOTH) Stock Quotes, Forecast and News Summary - Benzinga
Purple Biotech (NASDAQ:PPBT) Stock Quotes, Forecast and News Summary - Benzinga
Gelteq Ltd Stock (GELS) Financials Data
There is no financial data for Gelteq Ltd (GELS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):